5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3.

[1]  Paul W Smith,et al.  Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity. , 2008, Bioorganic & medicinal chemistry letters.

[2]  S. Bromidge,et al.  6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[3]  S. Bromidge,et al.  5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders. , 2008, Current topics in medicinal chemistry.

[4]  Paul W Smith,et al.  Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands. , 2007, Bioorganic & medicinal chemistry letters.

[5]  Paul W Smith,et al.  3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[6]  J. Hagan,et al.  Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B , 2007, Psychopharmacology.

[7]  D. Middlemiss,et al.  3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activity. , 2005, Bioorganic & medicinal chemistry letters.

[8]  M. Vaswani,et al.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  C. Beyer,et al.  Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study , 2002, Journal of psychopharmacology.

[10]  M. Wood,et al.  Therapeutic potential of serotonin antagonists in depressive disorders , 2002, Expert opinion on investigational drugs.

[11]  D. Middlemiss,et al.  Ligands for the investigation of 5-HT autoreceptor function , 2001, Brain Research Bulletin.

[12]  B. Leonard,et al.  A review of the role of serotonin receptors in psychiatric disorders , 2000, Human psychopharmacology.

[13]  M B Keller,et al.  Social functioning in depression: a review. , 2000, The Journal of clinical psychiatry.

[14]  R. Hirschfeld.  History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.

[15]  C. Montigny,et al.  Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic Disorders , 1999, Neuropsychopharmacology.

[16]  I. Lucki,et al.  The spectrum of behaviors influenced by serotonin , 1998, Biological Psychiatry.

[17]  Y. Kita,et al.  Synthetic Application of Lithiation Reactions : A Convenient Synthesis of 3, 4-Dihydro-5-hydroxycarbostyril, 1, 2, 3, 4-Tetrahydro-5-hydroxy-2-oxo-1, 7-naphthyridine, and Methyl 3-Methoxypyridine-4-carboxylate , 1982 .